https://www.expresshealthcare.in/news/qiagen-receives-cdsco-approval-for-neumodx-hiv-1-hbv-and-hcv-quant-assays/441221/
The NeuMoDx platform delivers fast turnaround times utilising an intuitive 3-step workflow for informed clinical decisions
Create an account or login to join the discussion